Brian Colin Horsburgh

Brian Colin Horsburgh

Chief Executive Officer at Modulate Therapeutics, Inc.

Commercial Services
Health Technology
Consumer Services

Profile

Brian Colin Horsburgh is the founder of Nurel Therapeutics, Inc. He is currently an Independent Director at Oil Spill Response Ltd.
and a Director at Modulate Therapeutics, Inc. He previously worked as a Director-Business Development at IP Group Plc, as well as a Director at Azellon Ltd.
and Amaethon Ltd.
Dr. Horsburgh obtained a doctorate degree from the University of Cambridge.

Brian Colin Horsburgh active positions

CompaniesPositionStart
Chief Executive Officer -
Director/Board Member -
All active positions of Brian Colin Horsburgh

Former positions of Brian Colin Horsburgh

CompaniesPositionEnd
Director/Board Member -
IP GROUP PLC Corporate Officer/Principal -
Founder -
Director/Board Member -
See the detail of Brian Colin Horsburgh's experience

Training of Brian Colin Horsburgh

University of Cambridge Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Brian Colin Horsburgh's experience

Connections

22

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
IP GROUP PLC

Commercial Services

Private companies5

Commercial Services

Health Technology

Commercial Services

Health Technology

Industrial Services

See company connections
  1. Stock Market
  2. Insiders
  3. Brian Colin Horsburgh